MedPath

Trianex 0.05%

Trianex 0.05% (Triamcinolone Acetonide Ointment)

Approved
Approval ID

cde13809-a606-12ca-aece-f2ae594baa71

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

May 12, 2021

Manufacturers
FDA

Promius Pharma, LLC

DUNS: 020408265

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Triamcinolone Acetonide Ointment

PRODUCT DETAILS

NDC Product Code67857-806
Application NumberANDA089595
Marketing CategoryC73584
Route of AdministrationTOPICAL
Effective DateMay 12, 2021
Generic NameTriamcinolone Acetonide Ointment

INGREDIENTS (7)

TRIAMCINOLONE ACETONIDEActive
Quantity: 0.5 mg in 1 g
Code: F446C597KA
Classification: ACTIB
LIGHT MINERAL OILInactive
Code: N6K5787QVP
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
PETROLATUMInactive
Code: 4T6H12BN9U
Classification: IACT
MINERAL OILInactive
Code: T5L8T28FGP
Classification: IACT
CERESINInactive
Code: Q1LS2UJO3A
Classification: IACT
LANOLIN ALCOHOLSInactive
Code: 884C3FA9HE
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Trianex 0.05% - FDA Drug Approval Details